The left atrial appendage closure devices market was estimated at USD 1.25 billion in 2022 and is likely to grow at a CAGR of 20.27% during 2023-2028 to reach USD 3.8 billion in 2028.
Left atrial appendage closure is a technique that assists in lowering the risk of stroke. It (LAA) is a small-sized, ear-shaped sac sited in the muscle wall of the left atrium. Left atrial appendage closure devices are used to reduce the possibility of blood clots, thus preventing stroke. They are implantable cardiac devices that are placed in the left atrial appendage for the prevention of stroke in patients.